1.Primary Sites and Clinicopathological Features of Corneal Melanoma: A Surveillance, Epidemiology, and End Results (SEER) Population-based Study of 29 Cases
Alexander W. SUH ; Sowmya RAVI ; Kenneth TRAN ; Minqi (Maggie) HUANG ; Isabelle LIAN ; Preston TSANG ; Elisa LEDET ; Jian LI ; Andre NGUYEN ; Peyton DANG ; Nguyen Duc Dinh DANG
Korean Journal of Ophthalmology 2025;39(1):23-30
Purpose:
Corneal melanoma (CM) is a rare malignancy that develops from melanocytes within the cornea, constituting a minority of all ocular tumors. In this study, we sought to investigate the clinicopathological characteristics correlated with the prognosis of CM patients.
Methods:
We collected patients with CM between 1983 and 2018 from the Surveillance, Epidemiology, and End Results (SEER) database. Cox proportional hazards regression was used for univariate analysis to value hazard ratio of malignant CM versus spindle cell melanoma and nodular melanoma subgroups. Kaplan-Meier survival analysis and log-rank test were also performed to identify additional prognostic markers and confirm the findings of the Cox hazard ratio.
Results:
A total of 29 eligible patients were collected in our study. Age at diagnosis, laterality, primary site, tumor size, the extent of disease, marital status, income, residential area, and treatment showed no significant prognostic factors for CM patients (p > 0.05). However, when concerned with the primary site of malignant melanoma, spindle cell melanoma and nodular melanoma were found to show significantly poorer prognosis in CM patients (both p < 0.05).
Conclusions
Age at diagnosis, laterality, primary site, tumor size, the extent of disease, and treatment were not significant prognostic indicators for CM patients. Spindle cell melanoma and nodular melanoma were notable for showing worse survival outcomes than malignant melanoma. Although the sample size in the SEER database was limited, our findings may provide motivation for tailoring individualized treatments for patients with CM with different primary sites.
2.Primary Sites and Clinicopathological Features of Corneal Melanoma: A Surveillance, Epidemiology, and End Results (SEER) Population-based Study of 29 Cases
Alexander W. SUH ; Sowmya RAVI ; Kenneth TRAN ; Minqi (Maggie) HUANG ; Isabelle LIAN ; Preston TSANG ; Elisa LEDET ; Jian LI ; Andre NGUYEN ; Peyton DANG ; Nguyen Duc Dinh DANG
Korean Journal of Ophthalmology 2025;39(1):23-30
Purpose:
Corneal melanoma (CM) is a rare malignancy that develops from melanocytes within the cornea, constituting a minority of all ocular tumors. In this study, we sought to investigate the clinicopathological characteristics correlated with the prognosis of CM patients.
Methods:
We collected patients with CM between 1983 and 2018 from the Surveillance, Epidemiology, and End Results (SEER) database. Cox proportional hazards regression was used for univariate analysis to value hazard ratio of malignant CM versus spindle cell melanoma and nodular melanoma subgroups. Kaplan-Meier survival analysis and log-rank test were also performed to identify additional prognostic markers and confirm the findings of the Cox hazard ratio.
Results:
A total of 29 eligible patients were collected in our study. Age at diagnosis, laterality, primary site, tumor size, the extent of disease, marital status, income, residential area, and treatment showed no significant prognostic factors for CM patients (p > 0.05). However, when concerned with the primary site of malignant melanoma, spindle cell melanoma and nodular melanoma were found to show significantly poorer prognosis in CM patients (both p < 0.05).
Conclusions
Age at diagnosis, laterality, primary site, tumor size, the extent of disease, and treatment were not significant prognostic indicators for CM patients. Spindle cell melanoma and nodular melanoma were notable for showing worse survival outcomes than malignant melanoma. Although the sample size in the SEER database was limited, our findings may provide motivation for tailoring individualized treatments for patients with CM with different primary sites.
3.Support system for children with special needs participating in physical activity in an inclusive education context
Dang WU ; Qing ZHANG ; Jiaming WU ; Wenrong JIA ; Aihong WU ; Jian WU
Chinese Journal of Rehabilitation Theory and Practice 2025;31(6):650-657
Objective To construct a support system that facilitates the participation of children with special needs(CSN)in physi-cal activity within the context of inclusive education.Methods Based on World Health Organization(WHO)health promoting school(HPS)framework,and integrating WHO International Classification of Functioning,Disability and Health(ICF)as well as the WHO guidelines on physi-cal activity,a systematic and multidimensional support framework was developed.Results In the context of inclusive education,the primary forms of physical activity for CSN included physical educa-tion classes and extracurricular sports activities.A comprehensive support system was developed at macro-,me-so-and micro-levels.At the macro-level,the framework called for the establishment of inclusive physical educa-tion and activity-related policies,accessible and universally designed physical environments,inclusive activity climates,and integrated community resources.At the meso-level,it emphasized creating a supportive profession-al development environment for inclusive physical education teachers,equipping them with skills in inclusive pedagogy,classroom management and extracurricular activity planning.At the micro-level,it focused on the de-sign of physical education curricula tailored to the physical activity and motor development needs of CSN,the es-tablishment of individualized learning support mechanisms,and encouraging active participation in physical edu-cation and physical activities.Conclusion To address the physical activity and educational needs of CSN in inclusive education settings,a three-tiered support system has been constructed.The macro-level involves policy,environment and community;the meso-level focuses on teachers and instructional practices;and the micro-level targets students'learning,motor devel-opment and health.
4.Primary Sites and Clinicopathological Features of Corneal Melanoma: A Surveillance, Epidemiology, and End Results (SEER) Population-based Study of 29 Cases
Alexander W. SUH ; Sowmya RAVI ; Kenneth TRAN ; Minqi (Maggie) HUANG ; Isabelle LIAN ; Preston TSANG ; Elisa LEDET ; Jian LI ; Andre NGUYEN ; Peyton DANG ; Nguyen Duc Dinh DANG
Korean Journal of Ophthalmology 2025;39(1):23-30
Purpose:
Corneal melanoma (CM) is a rare malignancy that develops from melanocytes within the cornea, constituting a minority of all ocular tumors. In this study, we sought to investigate the clinicopathological characteristics correlated with the prognosis of CM patients.
Methods:
We collected patients with CM between 1983 and 2018 from the Surveillance, Epidemiology, and End Results (SEER) database. Cox proportional hazards regression was used for univariate analysis to value hazard ratio of malignant CM versus spindle cell melanoma and nodular melanoma subgroups. Kaplan-Meier survival analysis and log-rank test were also performed to identify additional prognostic markers and confirm the findings of the Cox hazard ratio.
Results:
A total of 29 eligible patients were collected in our study. Age at diagnosis, laterality, primary site, tumor size, the extent of disease, marital status, income, residential area, and treatment showed no significant prognostic factors for CM patients (p > 0.05). However, when concerned with the primary site of malignant melanoma, spindle cell melanoma and nodular melanoma were found to show significantly poorer prognosis in CM patients (both p < 0.05).
Conclusions
Age at diagnosis, laterality, primary site, tumor size, the extent of disease, and treatment were not significant prognostic indicators for CM patients. Spindle cell melanoma and nodular melanoma were notable for showing worse survival outcomes than malignant melanoma. Although the sample size in the SEER database was limited, our findings may provide motivation for tailoring individualized treatments for patients with CM with different primary sites.
5.Advances in the Classification of Castleman Disease
JOURNAL OF RARE DISEASES 2025;4(4):500-505
Castleman disease (CD) is a rare and highly heterogeneous lymphoproliferative disorder, with clinical and pathological features ranging from asymptomatic localized lesions to life-threatening systemic inflammatory responses. In recent years, the classification system of CD has been increasingly refined, with both unicentric CD (UCD) and multicentric CD (MCD) expanding into multiple subtypes with distinct clinical characteristics. Although the classification framework has become more sophisticated, some subtypes still lack specific biomarkers, and the categorization of certain entities remains controversial. This review summarizes advances in CD classification approaches over the past years, explores the clinical features and identification of newly proposed subtypes, and analyzes current challenges, aiming to provide a reference for optimizing diagnostic and therapeutic strategies.
6.Clinical Characteristics of Patients With Idiopathic Multicentric Castleman Disease Complicated by Autoimmune Hemolytic Anemia.
Yu-Han GAO ; Li SI-YUAN ; Yue DANG ; Li JIAN ; Lu ZHANG
Acta Academiae Medicinae Sinicae 2025;47(1):10-15
Objective To investigate the clinical characteristics,treatment responses,and prognosis of patients with idiopathic multicentric Castleman disease(iMCD)complicated by autoimmune hemolytic anemia(AIHA). Methods The patients diagnosed with iMCD in Peking Union Medical College Hospital from January 2010 to December 2023 and having complete baseline blood routine data were retrospectively enrolled in the study.The iMCD patients were further assigned into AIHA and non-AIHA groups based on baseline laboratory examinations,and the clinical characteristics and prognosis were compared between the two groups. Results A total of 341 patients with iMCD were enrolled in this study,including 277(81.2%)exhibiting anemia at baseline.Five(1.8%)patients were identified as having iMCD-AIHA,all of whom were iMCD-not otherwise specified type complicated by warm antibody-type AIHA,and two of them were simultaneously diagnosed with Evans syndrome.The timing relationship between the first onset of AIHA and iMCD diagnosis varied,with 2 patients experiencing their first hemolytic episode prior to the diagnosis of iMCD.In terms of treatment,the therapy targeting iMCD was effective in alleviating AIHA.The AIHA group had a poorer prognosis(HR=4.61,95% CI=1.08-19.80,P=0.040)and a lower 5-year survival rate(90% vs.60%,P=0.024)than the non-AIHA group.Conclusions iMCD-AIHA is clinically rare,and AIHA can occur at different stages of iMCD.Although the primary treatment principle remains targeting iMCD,great attention should be paid to the exacerbation of immune dysfunction caused by AIHA and the possible adverse prognosis it may bring.
Humans
;
Anemia, Hemolytic, Autoimmune/diagnosis*
;
Castleman Disease/diagnosis*
;
Retrospective Studies
;
Male
;
Female
;
Prognosis
;
Adult
;
Middle Aged
;
Aged
;
Young Adult
;
Adolescent
7.Treatment of Idiopathic Multicentric Castleman's Disease With Sequential Thalidomide-Cyclophosphamide-Prednisone After Siltuximab:Report of One Case.
Yue DANG ; Jian LI ; Ya-Ping LUO ; Lu ZHANG
Acta Academiae Medicinae Sinicae 2025;47(3):483-486
Castleman's disease is a rare polyclonal lymphoproliferative disorder.This article reports the diagnosis and treatment of a 45-year-old female patient with idiopathic multicentric Castleman's disease.The patient presented recurrent fever,enlarged lymph nodes,and elevated levels of inflammation markers.After multiple serological examinations and tissue biopsies,she was diagnosed with hyaline vascular-type Castleman's disease.Initially,the patient received siltuximab targeting interleukin-6,which significantly improved her condition.Considering the cost and convenience of long-term treatment,she subsequently switched the therapy to an oral treatment regimen of thalidomide,cyclophosphamide,and prednisone (TCP),which maintained disease control.This report aims to highlight the diagnostic complexity and diversity of treatment options for idiopathic multicentric Castleman's disease,demonstrating the potential of the TCP regimen as a cost-effective treatment choice.
Humans
;
Castleman Disease/drug therapy*
;
Female
;
Middle Aged
;
Thalidomide/therapeutic use*
;
Prednisone/therapeutic use*
;
Cyclophosphamide/therapeutic use*
;
Antibodies, Monoclonal/administration & dosage*
8.Mechanistic study on circVAPA promoting the Hippo signaling pathway to inhibit liver regeneration via miR-101a-3p/TEAD3 axis
Jian ZHAO ; Yunhong DAI ; Yanli DANG
Chongqing Medicine 2025;54(5):1050-1058
Objective To explore the molecular mechanism of circular RNA(circ)VAPA promoting the Hippo pathway to inhibit liver regeneration through the miR-101a-3p/TEAD3 axis.Methods A mouse model of 70%partial hepatectomy-induced liver regeneration was constructed,and the expressions of circVA-PA,miR-101a-3p,and TEAD3 were analyzed.Mouse embryonic hepatocyte BNL CL.2 cells were transfected with siRNA or overexpression plasmids and divided into the VAPA-NC group,the VAPA-NC+miR-101a-3p mimic group,the VAPA-NC+miR-101a-3p mimic-NC group,the VAPA-OE group,the VAPA-OE+miR-101a-3p mimic group and the VAPA-OE+miR-101a-3p mimic-NC group.CCK-8 method and flow cytometry were used to analyze the proliferation,apoptosis,and cell cycle changes of hepatocytes.Immunofluorescence staining was used to analyze the nuclear translocation of YAP1.Quantitative Reverse Transcription Real-Time PCR(qRT-PCR)was used to analyze the expressions of key genes in the Hippo pathway.The dual-lu-ciferase reporter gene assay was used to verify the targeting relationships between circVAPA and miR-101a-3p,as well as between miR-101a-3p and TEAD3.Results The level of circVAPA gradually increased during liver regeneration(P<0.05),while the level of miR-101a-3p first increased and then decreased(P<0.05).When miR-101a-3p was overexpressed alone,the cell proliferation rate was the highest(P<0.05),but it had no effect on the cell apoptosis rate(P>0.05).When circVAPA was overexpressed alone,it had no effect both on the cell proliferation rate and apoptosis(P>0.05).After co-overexpression of circVAPA and miR-101a-3p,the cell proliferation rate significantly decreased,and the cell apoptosis significantly increased(P<0.05).When miR-101a-3p was overexpressed alone,a large number of cells entered into the S phase.After co-overex-pression of circVAPA and miR-101a-3p,a large number of cells were blocked in the G2/M phase.The phos-phorylation level of the Hippo upstream gene YAP1 significantly increased at 6 hours after liver regeneration(P<0.05)and then rapidly decreased.However,co-overexpression of circVAPA and miR-101a-3p did not af-fect the level of p-YAP1 and the nuclear translocation of YAP1(P>0.05).The expression levels of the Hip-po downstream gene CTGF and the transcription factor TEAD3 first increased and then decreased during liver regeneration(P<0.05),and there was no significant change in CYR61(P>0.05).After co-overexpression of circVAPA and miR-101a-3p,the expression level of CTGF increased(P<0.05).Knocking down or overex-pressing circVAPA did not affect the expression of TEAD3(P>0.05),while overexpressing miR-101a-3p could significantly inhibit the expression level of TEAD3(P<0.05).The dual-luciferase reporter gene assay confirmed the targeting relationships between circVAPA and miR-101a-3p,as well as between miR-101a-3p and TEAD3.Conclusion circVAPA promotes the Hippo pathway to inhibit liver regeneration through the miR-101a-3p/TEAD3 axis.
9.Primary Sites and Clinicopathological Features of Corneal Melanoma: A Surveillance, Epidemiology, and End Results (SEER) Population-based Study of 29 Cases
Alexander W. SUH ; Sowmya RAVI ; Kenneth TRAN ; Minqi (Maggie) HUANG ; Isabelle LIAN ; Preston TSANG ; Elisa LEDET ; Jian LI ; Andre NGUYEN ; Peyton DANG ; Nguyen Duc Dinh DANG
Korean Journal of Ophthalmology 2025;39(1):23-30
Purpose:
Corneal melanoma (CM) is a rare malignancy that develops from melanocytes within the cornea, constituting a minority of all ocular tumors. In this study, we sought to investigate the clinicopathological characteristics correlated with the prognosis of CM patients.
Methods:
We collected patients with CM between 1983 and 2018 from the Surveillance, Epidemiology, and End Results (SEER) database. Cox proportional hazards regression was used for univariate analysis to value hazard ratio of malignant CM versus spindle cell melanoma and nodular melanoma subgroups. Kaplan-Meier survival analysis and log-rank test were also performed to identify additional prognostic markers and confirm the findings of the Cox hazard ratio.
Results:
A total of 29 eligible patients were collected in our study. Age at diagnosis, laterality, primary site, tumor size, the extent of disease, marital status, income, residential area, and treatment showed no significant prognostic factors for CM patients (p > 0.05). However, when concerned with the primary site of malignant melanoma, spindle cell melanoma and nodular melanoma were found to show significantly poorer prognosis in CM patients (both p < 0.05).
Conclusions
Age at diagnosis, laterality, primary site, tumor size, the extent of disease, and treatment were not significant prognostic indicators for CM patients. Spindle cell melanoma and nodular melanoma were notable for showing worse survival outcomes than malignant melanoma. Although the sample size in the SEER database was limited, our findings may provide motivation for tailoring individualized treatments for patients with CM with different primary sites.
10.Support system for children with special needs participating in physical activity in an inclusive education context
Dang WU ; Qing ZHANG ; Jiaming WU ; Wenrong JIA ; Aihong WU ; Jian WU
Chinese Journal of Rehabilitation Theory and Practice 2025;31(6):650-657
Objective To construct a support system that facilitates the participation of children with special needs(CSN)in physi-cal activity within the context of inclusive education.Methods Based on World Health Organization(WHO)health promoting school(HPS)framework,and integrating WHO International Classification of Functioning,Disability and Health(ICF)as well as the WHO guidelines on physi-cal activity,a systematic and multidimensional support framework was developed.Results In the context of inclusive education,the primary forms of physical activity for CSN included physical educa-tion classes and extracurricular sports activities.A comprehensive support system was developed at macro-,me-so-and micro-levels.At the macro-level,the framework called for the establishment of inclusive physical educa-tion and activity-related policies,accessible and universally designed physical environments,inclusive activity climates,and integrated community resources.At the meso-level,it emphasized creating a supportive profession-al development environment for inclusive physical education teachers,equipping them with skills in inclusive pedagogy,classroom management and extracurricular activity planning.At the micro-level,it focused on the de-sign of physical education curricula tailored to the physical activity and motor development needs of CSN,the es-tablishment of individualized learning support mechanisms,and encouraging active participation in physical edu-cation and physical activities.Conclusion To address the physical activity and educational needs of CSN in inclusive education settings,a three-tiered support system has been constructed.The macro-level involves policy,environment and community;the meso-level focuses on teachers and instructional practices;and the micro-level targets students'learning,motor devel-opment and health.

Result Analysis
Print
Save
E-mail